drugset / Trial / NCT00958152
Drug-Drug Interaction Study of VCH-222 and Telaprevir in Healthy Subjects
RandomizedParallel-groupQuadruple-blind
Summary
The purpose of this study is to investigate the pharmacokinetics, safety, and tolerability of the co-administration of VCH-222 and telaprevir in healthy subjects.
Timeline
- Start
- 2009-08
- Primary completion
- 2010-01
- Completion
- 2010-01
Drugs
| Evaluation | Drug | Modality | Dose | Route |
|---|---|---|---|---|
| Subject | LOMIBUVIR | Small molecule | 400 mg | Oral |
| Subject | LOMIBUVIR | Small molecule | 750 mg | Oral |
| Subject | LOMIBUVIR | Small molecule | 1000 mg | Oral |
| Subject | Telaprevir | Small molecule | 1125 mg | Oral |